GR3035589T3 - Novel CC-1065 analogs having two CPI subunits. - Google Patents

Novel CC-1065 analogs having two CPI subunits.

Info

Publication number
GR3035589T3
GR3035589T3 GR20010400433T GR20010400433T GR3035589T3 GR 3035589 T3 GR3035589 T3 GR 3035589T3 GR 20010400433 T GR20010400433 T GR 20010400433T GR 20010400433 T GR20010400433 T GR 20010400433T GR 3035589 T3 GR3035589 T3 GR 3035589T3
Authority
GR
Greece
Prior art keywords
pct
formula
date mar
compounds
analogs
Prior art date
Application number
GR20010400433T
Other languages
Greek (el)
English (en)
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GR3035589T3 publication Critical patent/GR3035589T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Artificial Filaments (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Television Systems (AREA)
  • Television Receiver Circuits (AREA)
  • Stereophonic System (AREA)
GR20010400433T 1988-09-12 2001-03-15 Novel CC-1065 analogs having two CPI subunits. GR3035589T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (1)

Publication Number Publication Date
GR3035589T3 true GR3035589T3 (en) 2001-06-29

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400433T GR3035589T3 (en) 1988-09-12 2001-03-15 Novel CC-1065 analogs having two CPI subunits.

Country Status (14)

Country Link
US (1) US5541339A (enExample)
JP (1) JP3380237B2 (enExample)
KR (1) KR0137959B1 (enExample)
AT (1) ATE198335T1 (enExample)
AU (1) AU632288B2 (enExample)
CA (1) CA1340215C (enExample)
DE (1) DE68929275T2 (enExample)
DK (1) DK175458B1 (enExample)
FI (1) FI103668B1 (enExample)
GR (1) GR3035589T3 (enExample)
LV (1) LV12806B (enExample)
NO (1) NO303498B1 (enExample)
TW (1) TW217383B (enExample)
WO (1) WO1990002746A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149768T3 (es) * 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
EP2163256B1 (en) 2001-05-11 2015-09-02 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
CA2464419A1 (en) 2001-11-09 2003-05-22 Boehringer Ingelheim Pharmaceuticals, Inc. Benzimidazoles useful as protein kinase inhibitors
WO2004014905A1 (en) * 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
AU2003287160A1 (en) * 2002-10-15 2004-05-04 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
CA2531485C (en) * 2003-07-07 2013-03-26 Merck Patent Gmbh Malonamide derivatives
US20050209284A1 (en) * 2004-02-12 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Tec kinase inhibitors
JP2009504756A (ja) * 2005-08-17 2009-02-05 シェーリング コーポレイション 新規な高親和性のチオフェンベースおよびフランベースのキナーゼリガンド
MX338185B (es) 2007-01-25 2016-04-05 Dana Farber Cancer Inst Inc Uso de anticuerpos anti-egfr en el tratamiento de enfermedad mediada por egfr mutante.
EP2134854B1 (en) 2007-03-15 2015-04-15 Ludwig Institute for Cancer Research Ltd. Treatment method using egfr antibodies and src inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
WO2009023265A1 (en) 2007-08-14 2009-02-19 Ludwig Institute For Cancer Research Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
HUE035798T2 (en) 2008-11-03 2018-05-28 Syntarga Bv CC-1065 analogues and conjugates
HUE030846T2 (en) 2010-04-21 2017-06-28 Syntarga Bv Conjugates of cc-1065 analogs and bifunctional linkers
EP3721878A1 (en) 2012-10-22 2020-10-14 Arnold Glazier Methods for the effective treatment of metastatic cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
LT3092010T (lt) 2014-01-10 2018-10-25 Synthon Biopharmaceuticals B.V. Metodas, skirtas gryninimui cys-sujungtų antikūno-vaisto konjugatų
BR112016016490B1 (pt) * 2014-01-27 2022-11-29 Pfizer Inc Compostos de agentes citotóxicos bifuncionais, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
DK3160513T3 (da) 2014-06-30 2020-04-06 Glykos Finland Oy Saccharidderivat af en toksisk payload og antistofkonjugater deraf
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
TWI712605B (zh) * 2015-03-20 2020-12-11 美商輝瑞股份有限公司 含有ｃｔｉ藥效基團之雙功能性細胞毒性劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
DE3750612T2 (de) * 1986-12-19 1995-03-02 Upjohn Co Cc-1065 analoge.

Also Published As

Publication number Publication date
DK175458B1 (da) 2004-11-01
NO910958L (no) 1991-05-10
CA1340215C (en) 1998-12-15
WO1990002746A1 (en) 1990-03-22
NO303498B1 (no) 1998-07-20
DK41791D0 (da) 1991-03-08
KR0137959B1 (ko) 1998-05-15
LV12806A (en) 2002-03-20
US5541339A (en) 1996-07-30
KR900701801A (ko) 1990-12-04
TW217383B (enExample) 1993-12-11
AU4192289A (en) 1990-04-02
FI911193A0 (fi) 1991-03-11
DE68929275T2 (de) 2001-05-23
AU632288B2 (en) 1992-12-24
FI103668B (fi) 1999-08-13
FI103668B1 (fi) 1999-08-13
NO910958D0 (no) 1991-03-11
ATE198335T1 (de) 2001-01-15
DE68929275D1 (de) 2001-02-01
LV12806B (lv) 2002-05-20
JPH04500664A (ja) 1992-02-06
DK41791A (da) 1991-03-08
JP3380237B2 (ja) 2003-02-24

Similar Documents

Publication Publication Date Title
GR3035589T3 (en) Novel CC-1065 analogs having two CPI subunits.
TR200000197T2 (tr) Yeni bileşimler
DE3750612D1 (de) Cc-1065 analoge.
DK0631575T3 (da) Substituerede pyrimidiner samt deres anvendelse som fungicider
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
IL94915A0 (en) Substituted quinazolinones and pharmaceutical compositions containing them
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
FI865233A0 (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
DE3774286D1 (de) (2,2-bis(aminomethyl)-1,3-propandiol-n,n')platin-komplexe.
ES2153814T3 (es) Analogos de cc-1065 que tienen dos subunidades cpi.
SE9802574D0 (sv) Novel compounds
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
IT1213034B (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
ATE51001T1 (de) Koordinationsverbindungen von platin.
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
EP0043976A3 (en) Anti-tumor agent
ATE87314T1 (de) Platin-arzneimittel.
DK0544168T3 (da) Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler
ATE35981T1 (de) Harnstoffacrylderivate.
FR2665362B1 (fr) Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
FR2574798B1 (fr) Nouvelle adenosine substituee en n6 et medicament la contenant comme principe actif
ATE73444T1 (de) Chemische zusammensetzungen und verwendung als brennstoff-additive.
GT199400074A (es) Pirroles substituidos

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees